United Therapeutics Corp. (UTHR) Tops Q1 EPS Views
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $513.12 -1.51%
Financial Fact:
Income from continuing operations before income taxes: 239.1M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Income from continuing operations before income taxes: 239.1M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
United Therapeutics Corp. (Nasdaq: UTHR) reported Q1 non-GAAP EPS of $1.29, $0.65 better than the analyst estimate of $0.64. Revenue for the quarter came in at $165.6 million versus the consensus estimate of $178.02 million.
United Therapeutics reported non-GAAP EPS of $1.13 in Q210.
United Therapeutics reported non-GAAP EPS of $1.13 in Q210.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Therapeutics completes enrollment in PPF lung fibrosis trial
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
